Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain

被引：46
|
作者：
Bedaiwy, Mohamed A.
Casper, Robert F. [1 ]
机构：
[1] Univ Toronto, Div Reprod Sci, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada
[2] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
来源：
FERTILITY AND STERILITY | 2006年 / 86卷 / 01期
关键词：
D O I：
10.1016/j.fertnstert.2005.12.030
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
This pilot study examined the effect of a low-dose E and pulsed progestogen hormone therapy (HT) regimen for add-back during long-term GnRH-agonist therapy on bone mineral density (BMD) in five patients with stage IV endometriosis. Bone mineral density was stable after initiation of HT for the entire follow-up period (up to 10 years). One patient stopped her treatment on two occasions to conceive and was successful each time with delivery of a normal baby. No patient had return of pelvic pain after HT add-back.
引用
收藏
页码：220 / 222
页数：3
相关论文
共 50 条
  • [31] Treatment of chronic low back pain through intensive activation - An assessment of 10 years.
    Pfingsten, M
    Hildebrandt, J
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2001, 36 (09): : 580 - 589
  • [32] Setting the stage for pain relief: how treatment setting impacts interdisciplinary multimodal pain treatment for patients with chronic back pain
    Maser, Dustin
    Muessgens, Diana
    Kleine-Borgmann, Julian
    Kincses, Balint
    Schmidt, Katharina
    Elsenbruch, Sigrid
    Mueller, Daniel
    Bingel, Ulrike
    PAIN, 2024, 165 (12) : 2909 - 2919
  • [33] Pathogenetic aspects of treatment of patients with genital endometriosis and syndrome of chronic pelvic pain in combination with "proliferative genital syndrome"
    Grek, L.
    MEDICAL PERSPECTIVES-MEDICNI PERSPEKTIVI, 2018, 23 (02): : 97 - 103
  • [34] Fertility Outcomes After Laparoscopic Cystectomy in Infertile Patients with Stage III-IV Endometriosis: a Cohort with 6-10 years of Follow-up
    Sun, Ting-Ting
    Chen, Si-Kai
    Li, Xiao-Yan
    Zhang, Jun-Ji
    Dai, Yi
    Shi, Jing-Hua
    Jia, Shuang-Zheng
    Wu, Yu-Shi
    Leng, Jin-Hua
    ADVANCES IN THERAPY, 2020, 37 (05) : 2159 - 2168
  • [35] RETRACTED: GONADOTROPIN-RELEASING-HORMONE AGONIST PLUS ESTROGEN-PROGESTIN ADD-BACK THERAPY FOR ENDOMETRIOSIS-RELATED PELVIC PAIN (RETRACTED ARTICLE. SEE VOL 65, PG 211, 1996)
    FRIEDMAN, AJ
    HORNSTEIN, MD
    FERTILITY AND STERILITY, 1993, 60 (02) : 236 - 241
  • [36] How much does an MRI change over a period of up to 2 years in patients with chronic low back pain? Is a repeated MRI really necessary in the follow-up of patients with chronic low back pain?
    Tome-Bermejo, Felix
    Otero-Romero, Daniel
    Javier-Martinez, Elias
    Sutil-Blanco, Angel
    de la Rosa-zabala, Kelman Luis
    Aviles-Morente, Carmen
    Oliveros-Escudero, Beatriz
    Nunez-Torrealba, Alexa Anais
    Moreno-Mateo, Fernando
    Cervera-Irimia, Javier
    Mengis-Palleck, Charles Louis
    Garzon-Marquez, Francisco
    Plais, Nicolas
    Guerra-Gutierrez, Felix
    Alvarez-Galovich, Luis
    EUROPEAN SPINE JOURNAL, 2024, 33 (12) : 4563 - 4571
  • [37] MULTIDISCIPLINARY TREATMENT OF CHRONIC PAIN - LONG-TERM FOLLOW-UP OF LOW-BACK-PAIN PATIENTS
    NEWMAN, RI
    SERES, JL
    YOSPE, LP
    GARLINGTON, B
    PAIN, 1978, 4 (03) : 283 - 292
  • [38] 3 year-follow-up of bone mineral density after a randomised trial of 12-month treatment with a GnRH agonist (leuprorelin 3.75 mg) associated with 2 options of steroidal "Add-Back" regimens in patients with endometriosis
    Roux, C
    Lucas, C
    Briot, K
    Kolta, S
    Fechtenbaum, J
    Fernandez, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S173 - S173
  • [39] LONG-TERM ELAGOLIX plus ADD-BACK THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN FOR 48 MONTHS+12 MONTH POST-TREATMENT FOLLOW-UP: A SAFETY UPDATE ON BONE MINERAL DENSITY DATA OF A PHASE 3 STUDY.
    Simon, James A.
    Kim, Jin Hee
    Thomas, James W.
    Miller, Charles E.
    Chan, Anna
    Snabes, Michael C.
    FERTILITY AND STERILITY, 2024, 122 (04) : E157 - E157
  • [40] A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain
    Sallwa M. Alshehre
    Sheila Duffy
    Georgina Jones
    William L. Ledger
    Mostafa Metwally
    Reproductive Biology and Endocrinology, 18
12345